B97.4
Respiratory syncytial virus as the cause of diseases classified elsewhere
Clinical Classification Guidelines
Inclusion Terms
- RSV as the cause of diseases classified elsewhere
Excludes Type 1
- acute bronchiolitis due to respiratory syncytial virus (RSV) (J21.0)
- acute bronchitis due to respiratory syncytial virus (RSV) (J20.5)
- respiratory syncytial virus (RSV) pneumonia (J12.1)
Code First
- related disorders, such as:
- otitis media (H65.-)
- upper respiratory infection (J06.9)
Medical Intelligence & Overview
ICD-10 code B97.4 refers to diseases caused by the Respiratory Syncytial Virus (RSV) that are classified under different categories. RSV is a common virus that can lead to respiratory infections, especially in infants, young children, and older adults. When RSV is identified as the causative agent of other medical conditions, healthcare providers assign this specific code to categorize the underlying infectious source.
Causes & Symptoms
Clinical Causes: Infection with Respiratory Syncytial Virus (RSV) Transmission primarily through respiratory secretions via coughing, sneezing, or close contact Exposure to contaminated surfaces or objects Limited immunity in young children and immunocompromised individuals leading to infection
Key Symptoms: Runny nose Decrease in appetite Coughing Sneezing Fever Wheezing or difficulty breathing Rapid breathing or nasal flaring in severe cases Irritability in infants Lethargy or fatigue
Diagnostic & Treatment
Diagnosis Path: Nasal swab or washing to detect RSV antigens or RNA via rapid antigen tests or PCR Chest X-rays to assess lung involvement in severe cases Blood tests to evaluate overall health status Monitoring clinical symptoms for progression or severity
Treatment Protocols: Supportive care such as hydration and rest Use of humidified air or oxygen therapy in cases with breathing difficulties Medications like antipyretics for fever Bronchodilators may be considered in some cases to ease breathing Hospitalization for severe respiratory distress or dehydration In high-risk populations, prophylactic administration of palivizumab (a monoclonal antibody) may be recommended to prevent RSV infection
Clinical Advice & FAQs
Billing Guidance
Is B97.4 a billable ICD-10 code?
Yes, B97.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B97.4?
Clinical documentation must specify the nature of Respiratory syncytial virus as the cause of diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference